Oracle Health and Life Sciences Summit registration is open!

Seema Verma

Executive Vice President and General Manager, Oracle Health and Life Sciences

Seema Verma is the Executive Vice President and General Manager, Oracle Health and Life Sciences, where she has responsibility of Oracle's EHR (former Cerner) business as well as clinical trials and the health insurance portfolio.  She also is a Director on the Board of Lifestance, a public company focused on behavioral health.  In addition, she serves on the Board of the USC Price School Board of Councilors.

Before coming to Oracle, she served as a Senior Advisor to private equity firms TPG and Cressey & Co, serving on the Cressey Distinguished Executive Committee. She also served on the Board of Directors for Lumeris, Monogram, Wellsky, ClaimsXten, and ShiftKey. Additionally, she provided advisory services to a variety of early stage and large public health care companies, including national payers and technology companies focusing on strategy, value creation, and operations.

Seema was the former administrator of the Centers for Medicare and Medicaid Services (CMS) between 2017-2021. Confirmed by the Senate on a bi-partisan basis, she had one of the longest terms in modern CMS history. In this role, she oversaw a $1.4 trillion dollar budget and coverage for 145 million beneficiaries. She was responsible for federal policy and operations of Medicare, Medicaid, Health Insurance Exchanges, the Centers for Medicare & Medicaid Innovation (CMMI), and all federal quality and safety regulations. In this role she developed and implemented the federal administration's health care strategic plan across all programs to advance value-based care, innovation, interoperability, and price transparency while reducing drug prices, and regulations through her historic Patients over Paperwork initiative. CMS had numerous accomplishments during her tenure including delivering reduced premiums across Medicare Part D, Medicare Advantage, and individual insurance market as well as addressing the social determinants of health. Her pro-market policies advanced market competition, provided $35 insulin to seniors and advanced site neutral payments. Her leadership on the White House COVID Task Force led to the widespread adoption of telehealth, Hospital at Home, and no cost vaccines for the entire country.

Prior to her role at CMS, she founded and sold a national consulting company and worked as a VP for Policy and Planning for a public hospital, public health department, and health system.

In 2019, Seema was named as Modern Healthcare's #1 Most Influential Person in Healthcare and was part of the Top 25 Women Leaders. Her healthcare articles have been published in The Wall Street Journal, Washington Post, Health Affairs, Modern Healthcare, Newsweek, CNN, USA Today, STAT, and others.  She is a graduate of the University of Maryland, and John's Hopkins University School of Public Health.

Mike Sicilia

Executive Vice President and General Manager, Oracle Health and Life Sciences

An expert in industry cloud solutions, Sicilia is responsible for research and development, go-to-market strategies, and overall operations for Oracle’s industry business units. These units help distinct markets including retail, financial services, communications, healthcare, life sciences, hospitality, engineering and construction, food and beverage, local government, and energy and water solve their most complex business challenges.

In previous roles at Oracle, Sicilia held development and business management leadership responsibilities in the industry business units.

Prior to joining Oracle, Sicilia worked at Primavera Systems (acquired by Oracle in 2008), He joined the development team in 1993, where he worked as a software engineer. In 2006, he was named Primavera’s chief technology officer. As CTO, he set the technology direction for products and managed the global development team. Sicilia also led the technical and due diligence team that worked through the Oracle acquisition.

Sicilia has a BS in computer science from Saint Joseph’s University. He is a board member for the Friends of Father Judge High School where he assists in fundraising efforts for improvements and academic programs at his alma mater. He also works closely with Oracle’s Diversity and Inclusion team to create academic opportunities and career paths in technology for underrepresented groups. As part of that work, Sicilia helped spearhead an Oracle-led scholarship fund for Meharry Medical College School of Applied Computational Sciences.

Chris Boone

Global Vice President, Research Services, Oracle Health and Life Sciences

Christopher P. Boone, Ph. D., is an accomplished global executive and thought leader in clinical research informatics, real-world evidence, and health equity. He is currently the Group Vice President of Life Sciences Research Services at Oracle Corporation. His expertise extends to academia as an adjunct assistant professor at New York University. Chris's career highlights include transformative roles at AbbVie and Pfizer, where he led initiatives in health economics, outcomes research, and real-world data analytics.

Recognized as a transformative figure in healthcare, Chris has been honored with several prestigious awards, including The DataIQ 100 Most Influential People in Data, the Top 50 Leadership Excellence Awards, and the Emerging Pharma Leaders from Pharmaceutical Executive Magazine. His commitment to advancing healthcare is evident in his active participation on numerous influential committees, such as the Board of Directors for the American Society of Hematology Research Collaborative (ASH-RC), the Board of Governors for PCORI, and the Advisory Board of Mango Sciences.

Chris holds a B.S. in Management Information Systems, an M.S. in Healthcare Administration, and a Ph.D. in Public Affairs. His academic journey is complemented by executive education from the Harvard Kennedy School, reflecting his dedication to lifelong learning and leadership in health technology.

T.K. Anand

Executive Vice President, Oracle Health and Analytics

T.K. Anand is Executive Vice President, Product Development at Oracle Corporation, leading the healthcare and analytics product portfolios.

With a mission to improve healthcare outcomes and reduce costs, TK’s team is redefining the Oracle Health suite by delivering secure, cloud-based applications and AI-powered analytics that seamlessly connect patients, providers, payers, public health, and life sciences organizations. His team is building an open, intelligent platform that transforms electronic health records, revenue cycle management, population health, and research applications. By leveraging AI-driven innovation and an extensible partner ecosystem, they are advancing healthcare delivery, driving meaningful action, and shaping the future of data-driven, human-centered care.

With the exponential growth in data and the ability to manage it efficiently in the cloud, organizations are looking at analytics technologies to help extract value out of their data estate to make intelligent decisions and transform their business. TK’s analytics team builds platforms that enable customers to manage their data and analyze it to gain insights aided by artificial intelligence, machine learning, natural language understanding, and data visualization. This team also builds data lakes, warehouses and analytics applications for business functions such as finance, operations, supply chain, human resources, marketing, sales and service.

Prior to joining Oracle, T.K. spent more than 20 years at Microsoft working on enterprise software and cloud technologies. He holds degrees in computer science and engineering from the Indian Institute of Technology, Bombay and the University of Toronto.

Lawrence Tallon

Chief Executive, UK Medicines and Healthcare Products Regulatory Agency

Lawrence became the Chief Executive of the MHRA in April 2025. He joined the Agency at a pivotal time for UK healthcare and life sciences, with the Government setting out its aspirations in the NHS Ten-year Plan and the Life Sciences Sector Delivery Plan, both of which will be enabled by safe, agile and risk-proportionate regulation of medicines, novel treatments and technologies. Lawrence has described his plans for the MHRA to set the gold standard in safety and surveillance, to accelerate access to new medicines and treatments and to make a major contribution to research and innovation in UK life sciences.

Before joining the MHRA, Lawrence spent five years as Deputy Chief Executive at Guy’s and St Thomas’ (GSTT) NHS Foundation Trust, one of the largest and most prestigious healthcare provider organizations in the UK. During Covid-19, he secured vital international supplies of medical equipment for the Trust and the wider UK. He led the successful merger of GSTT with the Royal Brompton and Harefield hospitals in 2021, creating a power-house of cardio-respiratory medicine and research. His role included oversight of the organization’s strategy, technology, innovation, commercialization and multiple major strategic change programs.

In the decade prior to that, Lawrence worked in a range of executive strategy and leadership roles in university hospitals in the UK and Middle East. He was Director of Strategy, Planning and Performance at University Hospitals Birmingham, Managing Director of the Shelford Group of UK university hospitals and an Executive Director at Hamad Medical Corporation in Qatar, one of the leading academic medical centers in the Middle East.

Lawrence began his career working for the UK Government in Whitehall, as a fast stream civil servant at the Department of Health and Social Care, before working for the Secretary of State for Health and running the headquarters of the NHS Chief Executive. He worked on a range of high profile national policy issues, working across government and with No.10 Downing Street, Her Majesty’s Treasury and the Cabinet Office, and becoming a senior civil servant within the Department of Health and Social Care.

He holds Bachelor’s and Master’s degrees in History from the School of Oriental and African Studies in London, and a Master’s degree in Global Health Policy from Imperial College London. He is a fellow of the Sciana Network of European health leaders.

Patrick Conway

CEO, Optum

Dr. Conway was named CEO of Optum in 2025. Optum has 300K employee team members who serve over 127 million people with annual revenue exceeding $250 billion. It includes three main business units. Optum Health, with nearly 90,000 doctors and other clinicians, delivers clinical care and services in clinics, homes, ambulatory surgical centers, behavioral health, and other settings across the country and serves payers, large employers and the government. Optum Rx serves over 62 million people providing pharmacy care services and over 1.6 billion prescriptions per year. Optum Insight is a data and technology business that serves payers, health systems, life sciences, and others across the country. Collectively, Optum delivers health care services to help make the health system better for everyone.

Previously, Patrick served as chief executive officer of Optum Rx. In this role, he led an integrated pharmacy care services organization that is making drugs more affordable and creating a better experience for consumers, filling more than 1.6 billion retail, mail and specialty drug prescriptions annually. He joined Optum in February 2020 and previously served as the chief executive officer of Care Solutions, where he led a portfolio of care continuum businesses serving over 70 million people across acute and post-acute care, care in the home in-person and virtually, mental and behavioral care benefits and delivery, broad population and complex disease health management, specialty care and government health services.

Dr. Conway was president and chief executive officer of Blue Cross and Blue Shield of North Carolina from 2017-19. From 2011 to 2017, he served as Deputy Administrator for Innovation and Quality at the Centers for Medicare and Medicaid Services and as director of the Center for Medicare and Medicaid Innovation and the agency’s Chief Medical Officer. Before joining CMS, he oversaw clinical operations and quality improvement at Cincinnati Children’s Hospital Medical Center.

Dr. Conway is a practicing pediatric hospitalist. He was elected to the National Academy of Medicine in 2014, received the President’s Senior Executive Distinguished Service Award, and was a White House Fellow from 2007 to 2008. He earned his MD with high honors from Baylor College of Medicine, residency training at Boston Children’s Hospital, and Master of Science in clinical epidemiology from the University of Pennsylvania.